A Pilot Study of Neoadjuvant Nivolumab, Ipilimumab, and Intralesional Oncolytic Virotherapy for HER2-negative Breast Cancer
V. Nguyen, Katie M. Campbell, T. Nowicki, Nila Elumalai +7 more
2023Cancer Research Communications16 citations Open access
Semantic Scholar

